Market information: Honda will terminate its autonomous driving partnership with General Motors.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Jialiqi: It is planned to distribute a cash dividend of RMB 2.8 yuan every 10 shares. Jialiqi announced that it plans to distribute a cash dividend of RMB 2.8 yuan to all shareholders every 10 shares based on the company's existing total share capital of 82,975,500 shares, with a total cash dividend of RMB 23,233,100, accounting for 29.56% of the company's net profit attributable to shareholders of listed companies in the first three quarters of 2024. No bonus shares will be paid this time, and the capital reserve fund will not be converted into share capital, and the remaining undistributed profits will be carried forward to the next year.
Sichuan issued 30-year ordinary special local bonds, with a scale of 35.4 billion yuan, an issue interest rate of 2.2000%, a marginal multiple of 1.58 times and an expected multiple of 2.19.Today, these stocks changed their main positions to increase electronic stocks and sell computer stocks, with a large amplitude.-Today, there are 22 stocks in A shares with an amplitude of more than 20%; -N Boyuan, Shenhao Technology, Panda Dairy and other stocks are among the top in amplitude; The turnover rate is high-today, there are 58 A-shares with a turnover rate of over 30%; -N Boyuan, Giant Wheel Intelligence, Tianyu Digital and other stocks have the highest turnover rate; Main funds-today, the main funds flowed into electronics, communications, real estate, non-ferrous metals, light industry manufacturing and other sectors, and flowed out of computers, machinery and equipment, non-bank finance, power equipment, automobiles and other sectors; -vision china, Jianghuai Automobile, Woer Nuclear Materials, Xinyisheng and Runxin Technology have the largest net inflows, with net inflows of 749 million yuan, 699 million yuan, 693 million yuan, 626 million yuan and 622 million yuan respectively; -Oriental Fortune, Shanzi Hi-Tech, Leo, Straight Flush, and Tianyue Mathematics have the largest net outflows, with net outflows of 2.295 billion yuan, 1.237 billion yuan, 1.131 billion yuan, 872 million yuan and 871 million yuan respectively.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.
Japanese manufacturers' confidence index turned negative to the central bank's forecast in December. A short-term survey in Reuters, Japan, found that Japanese manufacturers' business confidence deteriorated further in December due to concerns about US protectionist policies. The survey of 505 large Japanese non-financial enterprises showed that manufacturers' confidence index fell from 5 in November to -1 in December, which was the first time since last February, and the number of pessimists exceeded optimists for the first time in 10 months. The loss of business confidence may cast a shadow over the Bank of Japan's forecast. The Bank of Japan had previously predicted that a steady recovery driven by rising wages and consumption would help inflation reach the 2% target in a sustainable way and justify further interest rate hikes. Many manufacturing industries have reported that business confidence has declined. Among electronic machinery manufacturers, steel and non-ferrous metal manufacturers, pessimists far exceed optimists.New World Development sold Artisan Lab in Kowloon, Hong Kong for HK$ 620 million. Sing Tao Daily quoted an unnamed insider as saying that New World Development sold Artisan Lab in San Po Kong, Kowloon for HK$ 620 million. This 22-storey building was completed in 2022, with a floor area of about 120,000 square feet.Wells Fargo: Reduce the target price of Dow Chemical from $60 to $55, and maintain the "overweight" rating.
Strategy guide 12-13
Strategy guide
Strategy guide 12-13
Strategy guide 12-13